Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 7 Aminocephalosporanic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117247928A details mutant acylase for 7-ACA. Offers greener, efficient production for reliable pharmaceutical intermediates supplier partners.
Advanced membrane filtration and enzymatic hydrolysis process for high-purity 7-ACA production, offering significant cost reduction and supply chain stability.
Patent CN104480181A reveals enzymatic D-7-ACA synthesis offering high purity and yield. This process enables cost reduction in pharmaceutical intermediates manufacturing and supply chain stability.
Advanced synthesis of cefpirome intermediate via novel silylation and iodination. Reduces waste, recovers iodine, and ensures high purity for pharmaceutical supply chains.
Patent CN104910188A reveals a one-pot synthetic method for cefazolin acid, offering high yield, reduced solvent use, and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN112707919B introduces a graphene-supported copper catalyst for synthesizing 3-decarbamoyl cefuroxime acid, offering high purity and reduced phosphorus waste.